10001-ACT-1 A MULTICENTER EXPLORATORY PHASE II STUDY OF NEOADJUVANT BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT GLIOMA - THE SECOND REPORT
Toshihide Tanaka, Ryota Tamura, Jun Takei, Yukina Morimoto, Akihiko Teshigawara, Kyoichi Tohmoto, Yuki Kuranari, Ryotaro Imai, Yohei Yamamoto, Yuzuru Hasegawa, Yasuharu Akasaki, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki · 2023
Read 10001-ACT-1 A MULTICENTER EXPLORATORY PHASE II STUDY OF NEOADJUVANT BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT GLIOMA - THE SECOND REPORT by Toshihide Tanaka, Ryota Tamura, Jun Takei, Yukina Morimoto, Akihiko Teshigawara, Kyoichi Tohmoto, Yuki Kuranari, Ryotaro Imai, Yohei Yamamoto, Yuzuru Hasegawa, Yasuharu Akasaki, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10710578.txt.
Description
Toshihide Tanaka and co-authors report a trial of drug treatment given before surgery for a harsh brain tumor, in a paper from 2023. The tumor type is malignant glioma, most often glioblastoma. One drug, bevacizumab, is standard before surgery in bowel cancer but not in brain tumors. The multi-center trial tested safety first, then looked for signs of gain.
Fifteen patients got the drug plus a chemo pill before their operations. Surgery followed about three weeks later. Two patients had severe side effects tied to the drugs, such as wound infection and low blood counts. Tumors shrank in nearly all cases, and patient function scores improved before surgery. Average time before the disease grew again was about nine and a half months. The authors call the plan safe and worth study for some patients.
Catalog record
| CREATOR | Toshihide Tanaka, Ryota Tamura, Jun Takei, Yukina Morimoto, Akihiko Teshigawara, Kyoichi Tohmoto, Yuki Kuranari, Ryotaro Imai, Yohei Yamamoto, Yuzuru Hasegawa, Yasuharu Akasaki, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |